Careteq Ltd. (CTQ) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 37.09K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.44
• Revenue Growth: -2.77%
• EPS Growth: 65.63%
• Country: AU
• Employees: 24
• Sector: Healthcare
• Sector Strength: 56
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 237,118,710
• 10 Day Avg. Volume: 16,577
• 30 Day Avg. Volume: 37,094
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Careteq Ltd. is struggling with profitability despite strong revenue growth. The company's technical indicators reflect weak momentum, and its valuation remains unattractive due to negative earnings and the absence of dividends. The key risks include ongoing losses, cash flow challenges, and bearish technical signals. Improvement in operational efficiency and cash management is necessary for a better outlook.

Careteq Ltd. Business Overview & Revenue Model

Company Description

Careteq Ltd. (CTQ) is a technology company specializing in health and aged care solutions. The company focuses on delivering innovative technology-driven products and services designed to enhance the quality of life for elderly individuals and those requiring specialized care. Careteq's core offerings include smart monitoring devices, telehealth solutions, and integrated software platforms that facilitate better healthcare management, communication, and safety for users and caregivers alike.

How the Company Makes Money

Careteq Ltd. generates revenue primarily through the sale and subscription of its health and aged care technology solutions. The company earns money by selling its smart monitoring devices and telehealth equipment to individual consumers, healthcare providers, and aged care facilities. Additionally, Careteq offers subscription-based services for its integrated software platforms, which provide ongoing revenue through service fees. These platforms typically include features like remote monitoring, data analytics, and communication tools, enhancing the value proposition for users and fostering long-term customer relationships. Significant partnerships with healthcare organizations and aged care facilities also contribute to its revenue by expanding its market reach and facilitating product integration into existing care systems.

Careteq Ltd. Financial Statement Overview

Summary

Careteq Ltd. is experiencing strong revenue growth, which is a positive sign for future potential. However, the company continues to face challenges with profitability, as evidenced by negative margins and net income. The balance sheet shows low leverage but declining equity, while cash flow statements highlight ongoing cash constraints. Overall, the company needs to improve operational efficiency and manage cash flows more effectively to achieve sustainable growth and profitability.

Income Statement

The company has shown significant revenue growth, with a 30.9% increase from 2023 to 2024. However, profitability remains a concern with negative net and gross profit margins. The net income margin is consistently negative, indicating ongoing losses. Despite an improvement in revenue, the company's EBIT and EBITDA margins are negative, reflecting challenges in operational efficiency and profitability.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio with low total debt, which suggests limited leverage and potential stability. However, the company's equity has decreased over time, reducing the equity ratio. The return on equity is negative due to net losses, indicating that the company is not generating profits from shareholders' equity.

Cash Flow

The company is facing negative free cash flow, although there is a slight improvement in operating cash flow compared to the previous year. The free cash flow to net income ratio is unfavorable, indicating cash flow challenges. The financing cash flow is positive, suggesting reliance on external funding to support operations.

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
7.23M	5.52M	4.43M	735.44K	146.46K
	Gross Profit
6.74M	-2.44M	4.14M	-2.03M	-1.33M
	EBIT
-520.27K	-3.67M	-5.14M	-2.59M	-1.97M
	EBITDA
-826.62K	-3.57M	-5.90M	-5.06M	-1.93M
	Net Income Common Stockholders
-2.67M	-4.33M	-5.25M	-5.23M	-1.91M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.25M	1.85M	4.50M	8.90M	202.05K
	Total Assets
6.82M	7.57M	8.02M	12.23M	926.87K
	Total Debt
192.98K	961.96K	0.00	75.28K	0.00
	Net Debt
-1.06M	-890.63K	-4.50M	-8.82M	-202.05K
	Total Liabilities
3.30M	4.02M	1.72M	2.61M	4.67M
	Stockholders Equity
1.97M	2.14M	6.30M	9.61M	-3.74M
Cash Flow		Free Cash Flow
-2.59M	-3.42M	-4.54M	-1.52M	-1.33M
	Operating Cash Flow
-1.30M	-2.53M	-4.52M	-1.50M	-1.32M
	Investing Cash Flow
-570.80K	-799.63K	-256.83K	-23.21K	-11.55K
	Financing Cash Flow
1.27M	687.55K	8.81M	1.50M	1.23M

Careteq Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CTQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.48 is Neutral, neither overbought nor oversold. The STOCH value of -25.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CTQ.

Careteq Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RHT	64 Neutral	AU$16.55M	140.00	-3.11%	―	89.13%	69.57%
MDR	57 Neutral	AU$57.38M	110.00	-8.34%	―	-5.27%	50.29%
Sector *	52 Neutral	$5.35B	3.81	-42.57%	2.86%	17.10%	1.33%
CTQ	42 Neutral		―	-39.44%	―	-2.77%	65.63%

Careteq Ltd. Corporate Events

Careteq Limited Reports Strong Q3 FY25 Performance and Strategic Growth

Careteq Limited has reported significant progress in its Q3 FY25 activities, with the integration of its 1-System platform nearing completion, which is expected to enhance operational efficiencies and profitability. The company has exceeded revenue growth projections while reducing overhead costs, and it maintains a positive EBITDA. Strategic partnerships, such as with Medic Alert, have expanded Careteq’s market reach, particularly in aged care and GP networks, positioning the company for sustainable growth and shareholder value.

Careteq Achieves Maiden EBITDA Profit and Reports Strong Half-Year Results

Careteq Limited has announced its half-year results for the period ending December 31, 2024, achieving a maiden EBITDA profit of $0.2 million from continuing operations, marking a significant turnaround from a loss in the previous corresponding period. The company has seen a 15.5% increase in group revenue and a 275.2% rise in normalized group EBITDA. Strategic transactions, including divesting the Sofihub business and acquiring the remaining stake in Embedded Health Solutions (EHS), have streamlined operations and enhanced focus on medication management and clinical governance. The integration of EHS and HMR Referrals is expected to drive further operational efficiencies and expand service offerings, positioning Careteq for continued growth and positive financial performance in FY25.

Careteq Limited Reports Revenue Growth and Strategic Acquisition

Careteq Limited reported a 15.5% increase in revenues for the half-year ending December 2024, with a significant reduction in losses compared to the previous year. The acquisition of the remaining 45% of Embedded Health Solutions Pty Ltd for $2.4 million underscores Careteq’s commitment to strengthening its position in medication management and clinical governance, potentially benefiting stakeholders by solidifying its market focus.

Careteq Partners with MedicAlert to Boost Medication Safety in Australia

Careteq Limited has announced a strategic partnership with MedicAlert Foundation Australia to enhance medication safety for Australians, particularly those with complex medical conditions. The collaboration aims to address medication-related harm by combining MedicAlert’s trusted medical identification services with Careteq’s expertise in medication management, offering enhanced healthcare services and access to critical resources. This partnership is expected to improve health outcomes and awareness of Home Medication Reviews, providing a significant safety net for Australians at risk of adverse drug reactions.